St. Jude Clinical Trials
Non-therapeutic study examining the feasibility, acceptance and impact of clinical WGS, WES and RNA sequencing in a pediatric oncology setting
This is a non-therapeutic clinical trial that is open to new St. Jude patients. The patient has:
- cancerous or non-cancerous tumor that has been newly diagnosed
- recurred after previous treatment
- not responded to previous treatment (refractory disease)
The protocol is also open to current St. Jude patients with recurrent or refractory disease, where biopsy or resection is being performed to establish the diagnosis and/or palliate symptoms.
This is a non-therapeutic clinical trial open to St. Jude patients only.
Participants have been pre-identified by the primary care team as an English-speaking, four-member family unit diagnosed with TP53 mutation.